Yazji Salim - Insider Non-Derivative Transactions at Oncternal Therapeutics, Inc. (ONCT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 3, 2024, Yazji Salim's relationship to Oncternal Therapeutics, Inc. (ONCT) is Officer (Chief Medical Officer), and currently has 128,635 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ONCT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Yazji Salim - Insider Non-Derivative Transactions of ONCT Common Stock

Yazji Salim - Insider Non-Derivative Transactions at ONCT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 4, 2024	F -- (Common Stock)	19742	0.5	128635
Jul 4, 2023	F -- (Common Stock)	16299	0.36	148377
Apr 15, 2023	P -- (Common Stock)	5000	0.3	164676
Apr 14, 2023	P -- (Common Stock)	10000	0.29	159676
Apr 13, 2023	P -- (Common Stock)	10000	0.29	149676
Jan 4, 2023	F -- (Common Stock)	9961	1.02	139676